« Back to Record
Citation APA

Pandolfo, M., Reetz, K., Darling, A., Rodriguez De Rivera, F. J., Henry, P. G., Joers, J., Lenglet, C., Adanyeguh, I., Deelchand, D., Mochel, F., Pousset, F., Pascual, S., Van Den Eede, D., Martin-Ugarte, I., Vilà-Brau, A., Mantilla, A., Pascual, M., Martinell, M., Meya, U., & Durr, A. (2022). Efficacy and Safety of Leriglitazone in Patients with Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES). Neurology: Genetics, 8(6), e200034. doi:10.1212/NXG.0000000000200034


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/370769

Pandolfo, M., Reetz, K., Darling, A., Rodriguez De Rivera, F. J., Henry, P. G., Joers, J., Lenglet, C., Adanyeguh, I., Deelchand, D., Mochel, F., Pousset, F., Pascual, S., Van Den Eede, D., Martin-Ugarte, I., Vilà-Brau, A., Mantilla, A., Pascual, M., Martinell, M., Meya, U., & Durr, A. (2022). Efficacy and Safety of Leriglitazone in Patients with Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES). Neurology: Genetics, 8(6), e200034. doi:10.1212/NXG.0000000000200034